Showing 41 - 56 results of 56 for search '"haematology"', query time: 0.04s Refine Results
  1. 41
  2. 42
  3. 43

    Fungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African Context by Emily Boakye-Yiadom, Alex Odoom, Abdul-Halim Osman, Onyansaniba K. Ntim, Fleischer C. N. Kotey, Bright K. Ocansey, Eric S. Donkor

    Published 2024-11-01
    “…The continuous increase in the population of individuals at risk of fungal infections in sub-Saharan Africa, such as HIV patients, tuberculosis patients, intensive care patients, patients with haematological malignancies, transplant (haematopoietic stem cell and organ) recipients and the growing global threat of multidrug-resistant fungal strains, raise the need for an appreciation of the region’s perspective on antifungal usage and resistance. …”
    Get full text
    Article
  4. 44

    Deep learning model for early acute lymphoblastic leukemia detection using microscopic images by Vatsala Anand, Prabhnoor Bachhal, Deepika Koundal, Arvind Dhaka

    Published 2025-08-01
    “…However, to enhance survival and quality of life for those afflicted by this aggressive haematological malignancy, more research and clinical trials are required to address the issues associated with resistance, relapse, and long-term toxicity. …”
    Get full text
    Article
  5. 45

    Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and design by Michael Dymock, James H. McMahon, David Griffin, Michelle Hagenauer, Tom L. Snelling, Julie A. Marsh, On behalf of the BOOST-IC Investigator Team

    Published 2025-07-01
    “…Participants from one of three immunocompromised subpopulations (people living with human immunodeficiency virus, solid organ transplants or haematological malignancies) are randomised to receive a one- or two-dose booster vaccination schedule using one of three COVID-19 vaccine brands (Pfizer, Moderna or Novavax) available in Australia. …”
    Get full text
    Article
  6. 46

    Dietary supplementation of formulated fish specific mineral mixture improved growth and health status of Indian major carps by ANJU VIJAYAN, ABHED PANDEY, UDEYBIR SINGH CHAHAL

    Published 2025-07-01
    “…Supplementation of formulated mineral mix in fish feed significantly improved growth performance, feed utilization, haematological parameters and blood metabolic profile whereas, the flesh quality of catla, rohu and mrigal also improved (non-significantly) and recorded best in T4 (formulated mineral mixture at 1.5% of total fish feed) in comparison to positive (T1) and negative (T2) control. …”
    Get full text
    Article
  7. 47

    Snakebite in north-eastern South Africa: clinical characteristics and risks for severity by Darryl Wood, Benjamin Sartorius, Richard Hift

    Published 2016-03-01
    “…All patients were admitted, assessed and standard haematological and biochemical tests were done. Patients were observed for a minimum of 12 hours’ observation. …”
    Get full text
    Article
  8. 48

    Acute and Subchronic Toxicity and LC-MS Fingerprinting of a Polyherbal Formulation (KNDBHU) used for COVID-19 Management by Kamal Nayan Dwivedi, Anurag Mishra, Rajesh Kumar ​ Singh

    Published 2023-05-01
    “…On physical signs and symptoms, weight growth, food intake, haematological parameters, biochemical parameters, and macroscopic and microscopic examination of organs, no major harmful effects were seen at any of these doses. …”
    Get full text
    Article
  9. 49

    Polypharmacy driven synergistic toxicities in elderly breast cancer chemotherapy drug management and adverse drug reactions: a mini review by Xiran Wang, Xiran Wang, Jin Yang, Jin Yang, Jieying Zhang, Jieying Zhang, Hong Yang, Hong Yang

    Published 2025-08-01
    “…Prospective geriatric-oncology cohorts reveal a median of eleven concomitant drugs and clinically relevant potential drug–drug interactions (rPDDI) in up to 75% of patients; each level-1 conflict almost doubles grade 3–4 non-haematological events, while polypharmacy-frailty indices outperform chronological age for predicting unplanned hospitalisation. …”
    Get full text
    Article
  10. 50

    Clinical and Aetiological Profile of Thrombocytopenia in Adults: A Cross-sectional Study by MD Hussain D Page, Preeti Gupta, Trupti Pisal

    Published 2025-07-01
    “…Introduction: Thrombocytopenia, characterised by low platelet count, is a common haematological condition associated with various infectious diseases, including dengue and malaria. …”
    Get full text
    Article
  11. 51

    The Predictive Power of the Cystatin C‐Creatinine Score in Assessing Frailty by Li Deng, Xin Zheng, Yue Chen, Chenan Liu, Jinyu Shi, Zhaoting Bu, Xiaoyue Liu, Hong Zhao, Shuqun Li, Bing Yin, Siyu Xing, Hanping Shi

    Published 2025-01-01
    “…Subgroup analyses were conducted to assess the score's consistency across age, sex and clinical conditions. Results Sixteen haematological markers were selected through LASSO regression. …”
    Get full text
    Article
  12. 52

    Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019) by Dionysios Neofytos, Antonio Pagliuca, Katherine Houghton, Edward Broughton, Maria Lavinea Novis de Figueiredo Valente, Lili Jiang, David A. Enoch, Beate Gruener, Raoul Herbrecht, Tobias Lahmer, Olivier Lortholary, Cléa Melenotte, Francesco Giuseppe De Rosa, Carolina Garcia-Vidal, Maria Jimenez, Maria Fernandez, Oliver Cornely

    Published 2024-10-01
    “…Mean (standard deviation) age was 56.8 (15.6) years, 66% were men and 62% had at least three comorbidities, most frequently haematologic malignancy (62%). Estimated clinical response rate at week 24 was 54.5% (95% confidence interval [CI], 38.2–66.5%) for primary treatment and 73.5% (95% CI, 62.7–81.1%) for salvage therapy. …”
    Get full text
    Article
  13. 53
  14. 54
  15. 55
  16. 56